AT59699B - Process for the preparation of therapeutically valuable double salts from morphine and narcotine. - Google Patents

Process for the preparation of therapeutically valuable double salts from morphine and narcotine.

Info

Publication number
AT59699B
AT59699B AT59699DA AT59699B AT 59699 B AT59699 B AT 59699B AT 59699D A AT59699D A AT 59699DA AT 59699 B AT59699 B AT 59699B
Authority
AT
Austria
Prior art keywords
morphine
narcotine
preparation
therapeutically valuable
double salts
Prior art date
Application number
Other languages
German (de)
Original Assignee
Boehringer & Soehne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer & Soehne filed Critical Boehringer & Soehne
Application granted granted Critical
Publication of AT59699B publication Critical patent/AT59699B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

   <Desc/Clms Page number 1> 
 
 EMI1.1 
 
 EMI1.2 
 
 EMI1.3 
 
 EMI1.4 
 
 EMI1.5 
 
 EMI1.6 
 

 <Desc/Clms Page number 2> 

   Beispiel 3. Phenoldisulfosaures Morphin-Narkotin@   
 EMI2.1 
    4'69   Teile phenoldisulfosaures Barium werden in 100 Teilen Wasser gelöst und mit einer wässerigen Lösung von '79 TeilenMorphinsulfat und    4'98   Teilen   Narkotinsulfat   versetzt. Man erwärmt einige Zeit auf dem Wasserbad, filtriert vom Bariumsulfat ab und dampft die Lösung im Vakuum ein. Das so erhaltene Salz ist schwer löslich in kaltem Wasser, leicht löslich in Alkohol und heissem Wasser. 



   Beispiel 4. Morphin-Dinarkotin-Salizylodisulfonat : 
 EMI2.2 
   3@7 Teile Salizyldisulfosäure   (Gazz. chim. ital. 18 [1888], Seite 347) werden in 50 Teilen   50 /igom   Alkohol gelöst, der   heissen     Lösung nacheinander 3@03 Teile Morphin (1 Molekül)   und   8@26 Teile Narkotin (2 Moleküle) zugefüge und hierauf   im Vakuum eingedampft. 



  Das so   erhaltene Salz ist schwer löslich   in heissem und kaltem Wasser, leicht löslich in Alkohol. 
 EMI2.3 
 
 EMI2.4 
 
 EMI2.5 
 werden wie im vorhergehenden Beispiel zur Lösung gebracht und die filtrierte   Lösung   im Vakuum eingedampft. Das Salz ist in kaltem Wasser schwer löslich, leicht   löslich   in Alkohol und heissem Wasser. 
 EMI2.6 
 
 EMI2.7 
   6@0 Torle Morphin   und 82 Teile Narkotin werden m 40 Teilen   Normalschwefelsäm'f   gelöst und im Vakuum eingeengt. Das Salz ist leicht löslich in Wasser und   verdünnten   Alkohol und unterscheidet sich hinsichtlich des Schmelzpunktes und der   Löslichkeit,   z. B in Wasser, wesentlich von einem blossen Gemisch der einzelnen Sulfate im molekularen Verhältnis.



   <Desc / Clms Page number 1>
 
 EMI1.1
 
 EMI1.2
 
 EMI1.3
 
 EMI1.4
 
 EMI1.5
 
 EMI1.6
 

 <Desc / Clms Page number 2>

   Example 3. Phenol disulfonic acid morphine narcotine
 EMI2.1
    4,69 parts of barium phenol disulfate are dissolved in 100 parts of water and mixed with an aqueous solution of 79 parts of morphine sulfate and 4,98 parts of narcotine sulfate. The mixture is warmed for some time on the water bath, the barium sulfate is filtered off and the solution is evaporated in vacuo. The salt thus obtained is sparingly soluble in cold water, easily soluble in alcohol and hot water.



   Example 4. Morphine Dinarkotine Salicylodisulfonate:
 EMI2.2
   3 @ 7 parts of salicyldisulfonic acid (Gazz. Chim. Ital. 18 [1888], page 347) are dissolved in 50 parts of 50 / igom alcohol, the hot solution successively 3 @ 03 parts of morphine (1 molecule) and 8 @ 26 parts of narcotine ( 2 molecules) and then evaporated in vacuo.



  The salt thus obtained is sparingly soluble in hot and cold water and easily soluble in alcohol.
 EMI2.3
 
 EMI2.4
 
 EMI2.5
 are brought to the solution as in the previous example and the filtered solution is evaporated in vacuo. The salt is sparingly soluble in cold water, easily soluble in alcohol and hot water.
 EMI2.6
 
 EMI2.7
   6 @ 0 Torle Morphine and 82 parts of narcotine are dissolved in 40 parts of normal sulfuric acid and concentrated in vacuo. The salt is easily soluble in water and dilute alcohol and differs in terms of melting point and solubility, e.g. B in water, essentially from a mere mixture of the individual sulfates in the molecular ratio.

 

Claims (1)

PATENT-ANSPRUCH : EMI2.8 wirkung bringt und die so erhaltenen Alkalordsalze nach einer der übtichen Methoden abscheidet. PATENT CLAIM: EMI2.8 brings effect and the alkali metal salts obtained in this way are deposited by one of the usual methods.
AT59699D 1911-07-04 1912-05-13 Process for the preparation of therapeutically valuable double salts from morphine and narcotine. AT59699B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE59699X 1911-07-04

Publications (1)

Publication Number Publication Date
AT59699B true AT59699B (en) 1913-06-25

Family

ID=5630123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT59699D AT59699B (en) 1911-07-04 1912-05-13 Process for the preparation of therapeutically valuable double salts from morphine and narcotine.

Country Status (1)

Country Link
AT (1) AT59699B (en)

Similar Documents

Publication Publication Date Title
AT59699B (en) Process for the preparation of therapeutically valuable double salts from morphine and narcotine.
DE254502C (en)
AT113002B (en) Process for the preparation of monoboric acid choline.
DE117095C (en)
CH234924A (en) Process for the preparation of pregnen- (4,5) -in- (20,21) -ol- (17) -one- (3) -ethylene-ketal- (3).
DE479016C (en) Process for the production of choline monoborate
DE489572C (en) Process for the preparation of pure dehydrocholic acid and its sodium salt
AT112734B (en) Process for the preparation of monocamphorates of the Solanaceae alkaloids.
AT65803B (en) Method for the preparation of cocaine isovalerate.
AT111249B (en) Process for the preparation of complex antimony compounds.
DE588160C (en) Process for the preparation of new calcium compounds
DE374097C (en) Process for the production of double compounds from caffeine which are easily soluble in water
DE532536C (en) Process for the preparation of sulfosalicylic acid compounds of quinine
DE467627C (en) Process for the preparation of N-methanesulfinic acid salts of secondary aromatic-aliphatic amines
AT147483B (en) Process for the preparation of compounds of methyl N-methyltetrahydronicotinate.
DE665793C (en) Process for the preparation of ª ‰ - (p-Oxyphenyl) -isopropylmethylamine
DE183328C (en)
DE231092C (en)
CH236519A (en) Process for the preparation of pregnen- (4,5) -in- (20,21) -ol- (17) -one- (3) -propylene ketal- (3).
DE628535C (en) Process for producing a quinine salt
AT224630B (en) Process for the preparation of the new α- (3-acetylamino-2,4,6-triiodophenoxy) -caproic acid, its alkyl esters and salts
DE710225C (en) Process for the preparation of compounds of dioxydialkylstilbenes
CH202370A (en) Process for preparing a sulfonic acid amide compound.
CH104723A (en) Process for the preparation of an easily soluble quinine salt.
DE1196207B (en) Process for the preparation of new quaternary ajmalinium salts